Nuclear Medicine Communications

Nuclear Medicine Communications

核医学通讯

  • 4区 中科院分区
  • Q3 JCR分区

期刊简介

《Nuclear Medicine Communications》是由Lippincott Williams and Wilkins Ltd.出版社于1980年创办的英文国际期刊(ISSN: 0143-3636,E-ISSN: 1473-5628),该期刊长期致力于核医学领域的创新研究,主要研究方向为医学-核医学。作为SCI、SCIE收录期刊(JCR分区 Q3,中科院 4区),本刊采用OA未开放获取模式(OA占比0.0599...%),以发表核医学领域等方向的原创性研究为核心(研究类文章占比90.78%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在141篇,确保学术质量与前沿性。成果覆盖Web of ScienceWeb of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Nuclear Medicine Communications审稿周期约为一般,3-8周。该刊近年未被列入国际预警名单,年发文量约141篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCI、SCIE 期刊收录
  • 141 发文量

中科院分区

《新锐期刊分区表》(2026年3月发布)

Top期刊 综述期刊 大类学科 小类学科
医学
4区
RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING 核医学
4区

期刊分区表(2025年3月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
4区
RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING 核医学
4区

期刊分区表(2023年12月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
4区
RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING 核医学
4区

期刊分区表(2022年12月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
4区
RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING 核医学
4区

期刊分区表(2021年12月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
4区
RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING 核医学
4区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING SCIE Q3 159 / 217

27

学科:RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING SCIE Q3 150 / 217

31.11

2024-2025年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING SCIE Q3 154 / 213

27.9

学科:RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING SCIE Q3 147 / 213

31.22

2023-2024年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING SCIE Q3 138 / 204

32.6

学科:RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING SCIE Q3 139 / 204

32.11

CiteScore(2026年6月最新版)

CiteScore SJR SNIP CiteScore 排名
CiteScore:2.4 SJR:0.399 SNIP:0.54
学科类别 分区 排名 百分位
大类:Medicine 小类:Radiology, Nuclear Medicine and Imaging Q3 206 / 361

43%

期刊发文

  • Development and validation of a nomogram for predicting positive [99mTc]Tc-HYNIC-PSMA SPECT/CT in patients with biochemically recurrent prostate cancer after radical prostatectom

    Author: Li, Bo; Yang, Guang; Ding, Xintao; Yu, Yue; Du, Yuqing; He, Feifei; Li, Wenliang; Wu, Xinyu; Gao, Yongju

    Journal: NUCLEAR MEDICINE COMMUNICATIONS. 2026; Vol. 47, Issue 5, pp. 510-520. DOI: 10.1097/MNM.0000000000002118

  • Correlation between 18 F-FDG PET/CT, Gd-EOB-DTPA MRI combined with laboratory parameters and microvascular invasion, and the potential of nomogram to predict microvascular invasion of hepatocellular carcinoma before liver transplantatio

    Author: Kong, Xianglei; Zhu, Mengting; Ye, Shengli; Cao, Guohong; Wang, Jiaqi

    Journal: NUCLEAR MEDICINE COMMUNICATIONS. 2026; Vol. 47, Issue 5, pp. 563-571. DOI: 10.1097/MNM.0000000000002117

  • Refining deep learning segmentation in gallium-68-prostate-specific membrane antigen-11 positron emission tomography: evaluation of small lesion filtering and intersection-over-union threshold

    Author: Huang, Yu-Yi; Yang, Shih-Han; Chen, Chi-Yuan; Shen, Yu-Jie; Chen, Yu-Hsin; Liou, Fou-Ming; Chen, Jyh-Cheng

    Journal: NUCLEAR MEDICINE COMMUNICATIONS. 2026; Vol. 47, Issue 5, pp. 552-562. DOI: 10.1097/MNM.0000000000002114

  • Evaluating the efficacy of the ResNet50 deep learning model utilizing thyroid scintigraphy images for predicting the outcomes of initial iodine-131 therapy in patients with Graves' diseas

    Author: Lu, Lu; Meng, Dongyun; Mo, Shaozhou; Sun, Zeyong; Song, Fengyang; Liao, Kehua; Huang, Wentan

    Journal: NUCLEAR MEDICINE COMMUNICATIONS. 2026; Vol. 47, Issue 3, pp. 286-297. DOI: 10.1097/MNM.0000000000002094

  • The relationship between posttreatment 18F-fluorodeoxyglucose PET/computed tomography restaging and metabolic parameters with the prognosis of uterine cervical cance

    Author: Hua, Yu; Wang, Bin; Su, Qian

    Journal: NUCLEAR MEDICINE COMMUNICATIONS. 2026; Vol. 47, Issue 3, pp. 315-324. DOI: 10.1097/MNM.0000000000002093

  • Structured hydration accelerates I-131 clearance, reduces bladder dose, and enables earlier discharg

    Author: Han, Jinfen; Liu, Manli; Wu, Guihong; Zhou, Miaoli; Xiong, Jinmei; Liao, Lijiao

    Journal: NUCLEAR MEDICINE COMMUNICATIONS. 2026; Vol. 47, Issue 3, pp. 298-303. DOI: 10.1097/MNM.0000000000002088

  • Post-therapy I-131 whole-body scan with SPECT/computed tomography-based mapping of residual metastatic lymph nodes in differentiated thyroid cance

    Author: Xu, Ruoxin; Wang, Bodong; Chen, Jianguo; Luo, Yao; Xu, Zeqing; Tang, Caihua

    Journal: NUCLEAR MEDICINE COMMUNICATIONS. 2026; Vol. 47, Issue 2, pp. 168-176. DOI: 10.1097/MNM.0000000000002083

  • Uptake pattern of dual-nuclide PET in intracranial lesion

    Author: Ren, Yutao; Meng, Qiang; Wu, Hao; Li, Huanfa; Li, Hui; Cui, Haohao; Ye, Xiaobo; Fang, Bo; Tang, Haipeng; Du, Changwang; Liu, Yong; Zhang, Hua

    Journal: NUCLEAR MEDICINE COMMUNICATIONS. 2026; Vol. 47, Issue 2, pp. 197-205. DOI: 10.1097/MNM.0000000000002080